May 13, 2008

 

Novus signs worldwide marketing agreement with BioResource

 

Press Release
 

 

Novus International, Inc., a leader in animal health and nutrition, has announced a worldwide agreement with emerging biotechnology company BioResource International, Inc (BRI).

 

The signed agreement states that Novus will be the exclusive worldwide marketer for BRI's patented enzyme technologies.

 

''We are pleased to enter into this partnership with Novus International to bring value through improved feed efficiency solutions to the global market,'' stated Dr. Giles Shih, co-founder and president of BioResource International, Inc.

 

''Novus brings strong customer relationships, technical expertise in all areas of animal production, and a wide ranging global reach that complement BRI''s strengths in the area of biotechnology development and innovation.''

 

BRI's enzymes provide animal producers with an excellent source of versatile and pellet stable enzymes that allow them to achieve improved animal performance and greater flexibility in dietary formulations.

 

''Novus is excited about bringing this technology into our CIBENZA™ feed additive enzyme portfolio.  It represents a strong strategic fit for our overall portfolio and is aligned with our drive to bring advanced feed technologies to the market,'' stated Giovanni Gasperoni, executive vice president, Marketing and Sales.  

 

About Novus International, Inc.

 

Novus International, Inc. is headquartered in St. Louis, Missouri, US and serves customers in more than 80 countries around the world. An industry leader in animal nutrition and health, Novus's products include feed additives, nutritional feed acid, feed supplements, organic trace minerals, feed preservative, and feed ingredients among other specialty ingredients.

 

About BioResource International, Inc.

 

BioResource International, Inc. (BRI), a privately held biotechnology company based in the Research Triangle Park of North Carolina, US, is focused on harnessing the natural power of enzymes to address unique agricultural and industrial concerns.